Madison, WI, United States of America

Anantha Sudhakar

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anantha Sudhakar: Innovator in Thrombin Receptor Antagonists

Introduction

Anantha Sudhakar is a notable inventor based in the United States. He has made significant contributions to the field of chemistry, particularly in the development of compounds that serve as thrombin receptor antagonists. His work is characterized by innovative processes that enhance the preparation of these important compounds.

Latest Patents

Anantha Sudhakar has been involved in the development of several patents, although he currently holds no patents. His latest patent applications include:

1. **Process For The Preparation Of Phosphonate Compounds Useful In The Preparation Of Himbacine Analogs** - This application discloses a process for the preparation of Compound 16, which is useful for preparing himbacine analogs that act as thrombin receptor antagonists.

2. **Exo- And Diastereo- Selective Syntheses Of Himbacine Analogs** - This application outlines a process for the preparation of himbacine analogs, also useful as thrombin receptor antagonists. The process utilizes a base-promoted dynamic epimerization of a chiral nitro center, showcasing advanced chemical techniques.

Career Highlights

Throughout his career, Anantha Sudhakar has worked with various companies, including George G. Wu and Anantha Sudhakar. His expertise in chemistry has allowed him to contribute to significant advancements in the field.

Collaborations

Anantha has collaborated with notable professionals, including his coworker Tao Wang. Their joint efforts have furthered research and development in the area of thrombin receptor antagonists.

Conclusion

Anantha Sudhakar is a dedicated inventor whose work in the preparation of thrombin receptor antagonists has the potential to impact the pharmaceutical industry significantly. His innovative approaches and collaborative efforts highlight his commitment to advancing chemical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…